These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 337944)

  • 1. Therapeutic trials in muscular dystrophy. III. Studies of microbial proteinase inhibitors in murine dystrophy.
    Enomoto A; Bradley WG
    Arch Neurol; 1977 Dec; 34(12):771-3. PubMed ID: 337944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscular dystrophy: inhibition of degeneration in vivo with protease inhibitors.
    Stracher A; McGowan EB; Shafiq SA
    Science; 1978 Apr; 200(4337):50-1. PubMed ID: 635570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed degeneration of dystrophic and normal muscle cell cultures treated with pepstatin, leupeptin, and antipain.
    McGowan EB; Shafiq SA; Stracher A
    Exp Neurol; 1976 Mar; 50(3):649-57. PubMed ID: 1253868
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of mouse muscular dystrophy with the protease inhibitor pepstatin.
    Schorr EE; Arnason BG; Aström KE; Darzynkiewicz Z
    J Neuropathol Exp Neurol; 1978 May; 37(3):263-8. PubMed ID: 660216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of murine muscular dystrophy with the proteinase inhibitor leupeptin.
    Sher JH; Stracher A; Shafiq SA; Hardy-Stashin J
    Proc Natl Acad Sci U S A; 1981 Dec; 78(12):7742-4. PubMed ID: 6950412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic trial with protease inhibitor (leupeptin) in chicken muscular dystrophy. A histologic and histochemical study.
    Nonaka I; Ishiura S; Takagi A; Sugita H
    Acta Neuropathol; 1982; 58(4):279-85. PubMed ID: 7158305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteinase inhibitors and muscle degeneration.
    Stracher A
    Muscle Nerve; 1982; 5(6):494. PubMed ID: 7133046
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice.
    Leto G; Tumminello FM; Gebbia N; Woynarowska B; Bernacki RJ
    Anticancer Res; 1990; 10(1):265-9. PubMed ID: 2334138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cellular proteinases in acute myocardial infarction. II. Influence of in vivo suppression of myocardial proteolysis by antipain, leupeptin and pepstatin on myocardial infarct size in the rat.
    Bolli R; Cannon RO; Speir E; Goldstein RE; Epstein SE
    J Am Coll Cardiol; 1983 Oct; 2(4):681-8. PubMed ID: 6350400
    [No Abstract]   [Full Text] [Related]  

  • 10. In vivo effects of protease inhibitors on chickens with hereditary muscular dystrophy.
    Hudecki MS; Pollina CM; Heffner RR
    J Clin Invest; 1981 Apr; 67(4):969-74. PubMed ID: 7204579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cellular proteinases in acute myocardial infarction. I. Proteolysis in nonischemic and ischemic rat myocardium and the effects of antipain, leupeptin, pepstatin and chymostatin administered in vivo.
    Bolli R; Cannon RO; Speir E; Goldstein RE; Epstein SE
    J Am Coll Cardiol; 1983 Oct; 2(4):671-80. PubMed ID: 6350399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hemorrhagic pancreatic necrosis in mice. Effects of proteinase inhibitors on its induction.
    Lombardi B; Rao KN
    Digestion; 1982; 23(1):57-64. PubMed ID: 6177572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pepstatins: aspartic proteinase inhibitors having potential therapeutic applications.
    Tumminello FM; Bernacki RJ; Gebbia N; Leto G
    Med Res Rev; 1993 Mar; 13(2):199-208. PubMed ID: 8445958
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastric ulcer therapy with a pepsin-inactivating peptide, pepstatin: a double-blind randomized clinical trial.
    Svendsen LB; Christiansen PM; Bonnevie O
    Scand J Gastroenterol; 1979; 14(8):929-32. PubMed ID: 394302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic trials on progressive muscular dystrophy.
    Satoyoshi E
    Intern Med; 1992 Jul; 31(7):841-6. PubMed ID: 1450492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chymostatin and other proteinase inhibitors on protein breakdown and proteolytic activities in muscle.
    Libby P; Goldberg AL
    Biochem J; 1980 Apr; 188(1):213-20. PubMed ID: 7406880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leupeptin, a protease inhibitor, decreases protein degradation in normal and diseased muscles.
    Libby P; Goldberg AL
    Science; 1978 Feb; 199(4328):534-6. PubMed ID: 622552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte protease activities in myotonic dystrophy: studies on effects of protease inhibitors.
    Goto I; Shinno N; Kuroiwa Y
    Eur Neurol; 1987; 26(2):126-8. PubMed ID: 3549315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of proteinase inhibitors on preimplantation embryos in the rat.
    Ichikawa S; Shibata T; Takehara Y; Tamada H; Oda K; Murao S
    J Reprod Fertil; 1985 Mar; 73(2):385-90. PubMed ID: 3838771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered protein synthesis and creatine kinase in breast muscle cell cultures from dystrophic chick embryos.
    Ionasescu V; Ionasescu R; White D; Feld R; Cancilla P; Kaeding L; Kraus L; Stern L
    J Neurol Sci; 1980 May; 46(2):157-68. PubMed ID: 7381511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.